Please use this identifier to cite or link to this item: https://dspace.univ-ouargla.dz/jspui/handle/123456789/13616
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMAHFOUD Nacera-
dc.contributor.authorBRAHAMIA Brahim-
dc.date.accessioned2017-06-
dc.date.available2017-06-
dc.date.issued2017-06-
dc.identifier.issn1938-2170-
dc.identifier.urihttp://dspace.univ-ouargla.dz/jspui/handle/123456789/13616-
dc.descriptionAlgerian business performance reviewen_US
dc.description.abstractHealth spending in Algeria grows significantly for over two decades, due to the combination of several factors related to the epidemiological and demographic transition, health care provision and the almost total social coverage of the Algerian population. Medication use, supported by social security agencies (CASNOS and CNAS) naturally follows this trend. The objective of this article is to study the extent of the evolution of drug expenditure in Algeria, while examining the main causes of this increase and the measures of control and reforms to reduce this bill A retrospective study was carried out over two decades for analyzing the rate of change of pharmaceutical expenditure. The increase in pharmaceutical products spending is one of the main causes of dysfunction in the Algerian health system and several reform measures have been taken by the Algerian authorities to remedy to constantly growing bill.en_US
dc.language.isofren_US
dc.relation.ispartofseriesnumero 11 2017;-
dc.subjectPharmaceutical productsen_US
dc.subjectConsumeren_US
dc.subjectHealth Expendituresen_US
dc.subjectReformen_US
dc.subjectAlgeriaen_US
dc.titleConsommation de médicaments et maîtrise des dépenses de santé en Algérieen_US
dc.typeArticleen_US
Appears in Collections:numéro 11 2017 V6 n1

Files in This Item:
File Description SizeFormat 
ABPR11F03.pdf490,51 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.